# Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome

> **NCT03717909** · PHASE2 · COMPLETED · sponsor: **University of Birmingham** · enrollment: 63 (actual)

## Conditions studied

- Wolfram Syndrome

## Interventions

- **DRUG:** Sodium Valproate 200Mg E/C Tablet
- **DRUG:** Sodium Valproate matched placebo

## Key facts

- **NCT ID:** NCT03717909
- **Lead sponsor:** University of Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-28
- **Primary completion:** 2024-11-15
- **Final completion:** 2024-11-15
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03717909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03717909, "Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03717909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*